Trial Profile
Extended clinical study of DSP-1958
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Mar 2022
Price :
$35
*
At a glance
- Drugs Thiotepa (Primary) ; Busulfan
- Indications Brain cancer; Lymphoma; Solid tumours
- Focus Adverse reactions
- Sponsors Sumitomo Dainippon Pharma
- 22 Mar 2022 Status has been changed to completed, as per Japan Pharmaceutical Information Center - Clinical Trials Information
- 01 Mar 2022 Results published in the International Journal of Hematology
- 04 Oct 2018 Planned number of patients changed from 50 to 80.